"Fantastic" clinical uptake driving revenue.
Replace the asterisks with aus biz (no space).
https://******.com.au/media/fantastic-clinical-uptake-driving-revenue?videoId=36704
Key points:
- Orthocell's (ASX: OCC) increasing revenue is hugely driven by the sale of their two approved products
- A partnership with Buy Horizons has allowed Orthocell to expand internationally
- The US market represents a huge opportunity for Orthocell, with plans already in place for expansion
"Fantastic" clinical uptake driving revenue. Replace the...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.045(11.0%) |
Mkt cap ! $90.11M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 45.5¢ | 41.0¢ | $283.8K | 653.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17615 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 2803 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |